.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Accenture
Chubb
UBS
Novartis
Baxter
US Army
Chinese Patent Office
Daiichi Sankyo

Generated: September 19, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Jiangsu Hansoh Pharm

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
16011AII6/14/2002JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDVINORELBINE TARTRATE USP
18810AII9/24/2005JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDGEMCITABINE HYDROCHLORIDE USP (NON-STERILE BULK DRUG SUBSTANCE)
24480III12/20/2010JIANGSU HANSOH PHARMACEUTICAL CO LTDOLANZAPINE NON-STERILE BULK DRUG SUBSTANCE
25625III12/23/2011JIANGSU HANSOH PHARMACEUTICAL CO LTDDULOXETINE HYDROCHLORIDE NON-STERILE BULK DRUG SUBSTANCE
29183AII6/10/2015JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDPEMETREXED DISODIUM HEMIPENTAHYDRATE, NON-STERILE, BULK DRUG SUBSTANCE
28758AII12/8/2014JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDPEMETREXED DIACID, NON-STERILE, BULK DRUG SUBSTANCE
30041AII1/28/2016JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDOLANZAPINE USP, NON-STERILE
31106AII12/16/2016JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDICATIBANT ACETATE
31481AII3/24/2017JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDGEMCITABINE HYDROCHLORIDE USP
31480AII4/13/2017JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTDVINORELBINE TARTRATE, USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Merck
Deloitte
Baxter
Healthtrust
Boehringer Ingelheim
Teva
AstraZeneca
McKesson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot